NM

Nagula Malyala Lavanya

Active Director Director DIN 11124708
DIN 11124708 First appointment May 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Nagula Malyala Lavanya

Data last updated:

Nagula Malyala Lavanya is a Director at Reatas Pharmaceuticals Private Limited (since 2025). The company operates in Pharma.

DIN 11124708
Primary Designation Director
Industry Pharma
First Appointment 26 May 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director26 May 20252025Active

Board colleagues of Nagula Malyala Lavanya

NameDINCompanyDesignation
Bashaveni Keertana08925228Reatas Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Reatas Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Nagula Malyala Lavanya

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nagula Malyala Lavanya

Nagula Malyala Lavanya currently holds 1 directorship: Reatas Pharmaceuticals Private Limited (Director, since 26 May 2025).

Nagula Malyala Lavanya was first appointed on 26 May 2025 as Director at Reatas Pharmaceuticals Private Limited.

The current boards of Nagula Malyala Lavanya's companies include Bashaveni Keertana (Reatas Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available